home / press / releases

Menu
  • Search all tables

releases: https://sewell.house.gov/2022/3/rep-sewell-votes-cap-monthly-insulin-costs-35

One row per release. Full-text search runs over title + body text.

Data license: MIT · Data source: dwillis/congress-press

This data as json

url title date year month party chamber state member_name bioguide_id domain scraper source date_source text has_text collected_at updated_at
https://sewell.house.gov/2022/3/rep-sewell-votes-cap-monthly-insulin-costs-35 Rep. Sewell Votes to Cap Monthly Insulin Costs at $35 2022-03-31 2022 2022-03 Democrat House AL Terri A. Sewell S001185 sewell.house.gov sewell https://sewell.house.gov/press-releases scraper Washington, D.C. – Today, U.S. Rep. Terri Sewell (AL-07) voted to pass H.R. 6833, the Affordable Insulin Now Act. This bill would cap out-of-pocket costs for insulin at no more than $35 per month in Medicare Part D and commercial health insurance, ensuring vital and affordable access to this life-saving medication for the more than 37 million people in the United States who have diabetes. The Affordable Insulin Now Act passed the House of Representatives today by a vote of 232 to 193. “Alabamians are being crushed by the astronomical cost of insulin which is forcing families across our state to choose between putting food on the table or purchasing this life-saving medication,” said Rep. Sewell. “This is unacceptable and it’s why I was proud to join my colleagues in voting to pass the Affordable Insulin Now Act to ensure that no Alabamian pays more than $35 dollars per month for insulin.” Insulin is too expensive for millions of Americans, with 1 in 4 Americans who rely on insulin cutting back on or skipping doses due to costs. 34 percent of families with children dependent on insulin have been impacted by rising insulin costs, including adverse health effects and increased stress and anxiety. 26 percent of Americans with diabetes ration their insulin at least once a year—putting themselves at grave health risk because of cost. In 2018, more than a dozen people died while rationing their insulin due to the high cost. Insulin prices in the United States are much higher than other countries and continue to increase, with Americans paying more than 10 times the price of insulin compared to other similar high-income countries. From 2014 to 2019, the average retail price of insulin rose by 54 percent. 1 2026-03-30T01:40:41Z 2026-04-08T02:06:17Z
Powered by Datasette · Queries took 0.962ms · Data license: MIT · Data source: dwillis/congress-press